The Covid-19 pandemic has been awful for many reasons. But if there is a bright side to the past three years, it is vaccines. Development and testing has advanced at an unprecedented pace since the arrival of Covid-19, enabling technologies that might otherwise have taken another decade to undergo late-stage clinical testing, regulatory approval and manufacturing scale-up to prove their mettle in millions of people.
These advances have set the stage for further breakthroughs in the next five to 10 years that could help to combat some of the greatest scourges of humanity, from common respiratory infections to cancer.
